Dissociation of natriuresis and diuresis and heterogeneity of the effector system of atrial natriuretic factor in...

Area of Science:

• Biochemistry
• Physiology
• Pharmacology

Background:

• Human atrial natriuretic factor-(99-126) (hANF) induces hypotensive, natriuretic, and diuretic effects, associated with increased cyclic guanosine monophosphate (cGMP).
• The oxidized analogue, human [Met-O110]ANF-(99-126) (Met-O-ANF), was previously reported to lack cGMP-elevating capacity.

Purpose of the Study:

• To investigate the relationship between the biological actions of Met-O-ANF and cGMP generation.
• To use cGMP as a marker for ANF's stimulation of particulate guanylate cyclase.
• To determine if diuretic and natriuretic effects of ANF can be dissociated.

Main Methods:

• Comparing the biological effects (hypotensive, vasorelaxant, diuretic, natriuretic) and cGMP increases of Met-O-ANF and hANF.
• Assessing Met-O-ANF's effects on cGMP in cultured smooth muscle and endothelial cells.
• Analyzing Met-O-ANF's impact on urinary cGMP and its action on cGMP in isolated kidney fractions (glomeruli, collecting duct, thick ascending limb).

Main Results:

• Met-O-ANF acted as a partial agonist with lower potency than hANF across various functions.
• Met-O-ANF induced lower cGMP increases in cultured cells and required higher doses to elevate plasma and urinary cGMP.
• Diuresis was induced by Met-O-ANF without accompanying natriuresis or increased urinary cGMP, dissociating these effects.
• Met-O-ANF's cGMP-elevating action varied significantly across kidney fractions, being lowest in glomeruli and collecting duct.

Conclusions:

• The diuretic and natriuretic effects of ANF are mediated by distinct mechanisms and occur at different physiological sites.
• Natriuresis is associated with extracellular cGMP elevation, while diuresis is not necessarily linked to cGMP.
• Tissue-specific variations in ANF's biological and biochemical effects suggest heterogeneity in the ANF effector system.